Pristyn Care Reveals Robust Financial Growth and Future Plans

Pristyn Care reports a 28% revenue boost and a 42% reduction in EBITDA burn for 2023-24, attributed to increased organic patient traffic. The healthcare provider aims for a 35% revenue rise in 2024-25 with further operational efficiency, targeting profitability by 2026 and an IPO by 2028.

Pristyn Care, a leading name in India's healthcare sector focusing on secondary care surgeries, has unveiled its audited financials for the fiscal year 2023-24, reflecting impressive growth and operational improvements. With a consolidated revenue achievement of Rs632 crore, the company sees a substantial 28% increase compared to the previous year.

The key highlight was a dramatic 42% reduction in EBITDA burn within its secondary care surgery segment. This accomplishment is largely credited to the surge in organic patient inflow, which expanded from less than 40% to nearly 60%, significantly cutting down on marketing expenses by 60%.

Looking ahead to 2024-25, the company forecasts a further 35% rise in revenue, along with an ambitious 60%+ reduction in EBITDA burn. Pristyn Care's strategic investments in advanced medical technology and enhanced insurance partnerships are pivotal to these projections. The company, operating over 30 cities with 100 clinics and partnering with 200 hospitals, is steering towards profitability by 2026 and preparing for a potential IPO by 2028.

(With inputs from agencies.)